These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2993000)

  • 1. Increase in nigral type II benzodiazepine recognition sites following striatonigral denervation.
    Porceddu ML; Corda MG; Sanna E; Biggio G
    Eur J Pharmacol; 1985 Jun; 112(2):265-7. PubMed ID: 2993000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striato-nigral denervation increases type II benzodiazepine receptors in the substantia nigra of the rat.
    Corda MG; Concas A; Porceddu ML; Sanna E; Biggio G
    Neuropharmacology; 1986 Jan; 25(1):59-62. PubMed ID: 3005905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional changes in rat nigral GABA(A) receptors induced by degeneration of the striatonigral GABAergic pathway: an electrophysiological study of receptors incorporated into Xenopus oocytes.
    Sanna E; Motzo C; Usala M; Pau D; Cagetti E; Biggio G
    J Neurochem; 1998 Jun; 70(6):2539-44. PubMed ID: 9603220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential localization of type I and type II benzodiazepine binding sites in substantia nigra.
    Lo MM; Niehoff DL; Kuhar MJ; Snyder SH
    Nature; 1983 Nov 3-9; 306(5938):57-60. PubMed ID: 6314146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Denervation supersensitivity for benzodiazepine receptors in the rat substantia nigra.
    Biggio G; Corda MG; Concas A; Gessa GL
    Brain Res; 1981 Sep; 220(2):344-9. PubMed ID: 6269689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of girisopam (a 2,3-benzodiazepine derivative) to the substantia nigra is prevented by lesioning of the striatonigral pathway.
    Palkovits M; Lovas G; Horváth E
    Neuroscience; 1998 Apr; 83(3):799-806. PubMed ID: 9483563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
    Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
    Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of benzodiazepine receptor changes in substantia nigra, globus pallidus and entopeduncular nucleus after striatal lesions.
    Pan HS; Penney JB; Young AB
    J Pharmacol Exp Ther; 1984 Sep; 230(3):768-75. PubMed ID: 6147405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotransmitter receptor localizations: brain lesion induced alterations in benzodiazepine, GABA, beta-adrenergic and histamine H1-receptor binding.
    Chang RS; Tran VT; Snyder SH
    Brain Res; 1980 May; 190(1):95-110. PubMed ID: 6103733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA and benzodiazepine receptors in the cat motor thalamus after lesioning of nigro- and pallidothalamic pathways.
    Kultas-Ilinsky K; Hughes B; Fogarty JD; Ilinsky IA
    Brain Res; 1990 Mar; 511(2):197-208. PubMed ID: 2159356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence suggesting denervation supersensitivity of nigral GABA receptors following destruction of the striatonigral GABA pathway in the rat [proceedings].
    Cross AJ; Waddington JL
    J Physiol; 1978 Sep; 282():30P-31P. PubMed ID: 214545
    [No Abstract]   [Full Text] [Related]  

  • 12. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dramatic increase in nigral t-[35S]butylbicyclophosphorothionate binding sites elicited by the degeneration of the striato-nigral GABAergic pathway: reversal by diazepam.
    Sanna E; Serra M; Pepitoni S; Biggio G
    Brain Res; 1989 Oct; 501(1):144-9. PubMed ID: 2553212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic differentiation of multiple benzodiazepine receptors by detergent solubilization and pharmacologic specificity.
    Lo MM; Niehoff DL; Kuhar MJ; Snyder SH
    Neurosci Lett; 1983 Aug; 39(1):37-44. PubMed ID: 6314190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo [3H]flunitrazepam binding: imaging of receptor regulation.
    Ciliax BJ; Penney JB; Young AB
    J Pharmacol Exp Ther; 1986 Aug; 238(2):749-57. PubMed ID: 3016249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of benzodiazepine binding sites after short-wave photo-affinity labeling with flunitrazepam.
    Herblin WF
    Life Sci; 1986 Feb; 38(6):507-14. PubMed ID: 3003483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The striatonigral GABA pathway: functional and neurochemical characteristics in rats with unilateral striatal kainic acid lesions.
    Waddington JL; Cross AJ
    Eur J Pharmacol; 1980 Oct; 67(1):27-32. PubMed ID: 6252027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat.
    Paturle L; Fage D; Fourrier O; Vernier P; Feuerstein C; Demenge P; Scatton B
    Brain Res; 1987 Feb; 402(2):383-6. PubMed ID: 3828803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-aminobutyric acidA and benzodiazepine receptor alterations in the rat brain after unilateral 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T; Matsubara M; Fujihara K; Kato H; Imai Y; Itoyama Y
    Neurol Res; 2002 Jan; 24(1):107-12. PubMed ID: 11783749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of content with synthesis, uptake and breakdown of GABA in substantia nigra of unoperated, hemitransected and kainate-treated rats.
    Starr M; Kilpatrick I
    Life Sci; 1981 Nov; 29(22):2281-7. PubMed ID: 7321760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.